Belite Bio Announces FDA Acceptance And Priority Review Of Tinlarebant NDA For Stargardt Disease Type 1, With PDUFA Date Of February 12, 2027

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.